ClinicalTrials.gg
CompletedNCT02410434Updated Apr 13, 2016

Reducing Lesbian, Gay , Bisexual and Transgender (LGBT) Stigma in Swaziland and Lesotho

An interventional study of LGBT Stigma Reduction Intervention in Social Stigma, sponsored by University of Toronto. Completed at 2 sites in 2 countries. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-13.

Sponsored by University of Toronto · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The specific objectives of this study are reduce stigma towards lesbian, gay, bisexual, and transgender persons in Swaziland and Lesotho, using performance ethnography at community roundtables.

Read the detailed description

This project aims to develop performance ethnography approaches to reduce stigma towards lesbian, gay, bisexual and transgender (LGBT) persons in Swaziland and Lesotho by holding performance ethnography at community roundtables in Swaziland and Lesotho.

This project involved a critical ethnography with in-depth individual interviews conducted with LGBT communities in Swaziland and Lesotho. Following this, the investigators conducted a performance ethnography that involved: a) presenting theatre specialists and PRAs with the qualitative data; b) working together to highlight narratives, themes and visual images from this data; c) developing scripts for participatory theatre performances; d) implementing the theatre performances at community roundtables, with participants completing a pre and post-test and 6 week follow up.

The investigators will implement 2 interconnected KTE strategies in each location (Swaziland, Lesotho): (1) participatory theatre (PT) training/development and (2) community roundtables. (1) Participatory theatre (PT) training with SGM: The investigators will engage 6 SGMY (2 MSM, 2 WSW, 2 transgender) as PRA in each location. PRA will work with a theatre specialist to develop 3 short plays to highlight lived experiences of a) stigma and discrimination and b) resilience among MSM, WSW and trans persons. PRA will undertake a 4-week PT training program, including: PT processes; assessing. Phase 1 data; developing scenes; and production. PRA will work with community animators who will perform the scenarios to protect the privacy of the PR.

The investigators will implement community roundtables are to: a) raise awareness of SGM issues and b) reduce stigma. Purposive sampling will be employed to engage diverse stakeholders. Roundtables, 2 hours in duration, will be cofacilitated by PRA. The aim is to conduct 2 meetings in Swaziland and 2 in Lesotho, each with 20-25 participants, including groups identified as key to SGM wellbeing in Phase 1 (e.g. educators; law enforcement; civil society; LGBTQ groups). Community animators will enact the 3 plays developed by SGM using PT techniques. Plays will address narratives of stigma and discrimination that emerge in Phase 1 among SGM participants. Community animators will perform each play once to illustrate the situation and problem; the story will culminate in a crisis with no solution offered. Each play will be performed a second time, and roundtable participants can 'stop' the action at any point where there is a challenge. The participant that 'stops' the play will come up and replace the character and depict a possible solution or 'intervention.

To evaluate the project's outcomes the investigators will conduct cross-sectional surveys with roundtable participants (n=100) who will complete a pre/post-test evaluation and 6 week follow up. The primary outcome will be measured using the 'Attitudes Towards Lesbians and Gay Men Scale' (ATLG-R) to assess changes in phobia, stigma and knowledge regarding SGM issues following the participatory theatre event. The survey will also include questions about attitudes towards HIV related stigma. Socio-demographic information will be collected from all survey participants including age, gender, highest level of education, nationality, marital status, current household income, type of work, number of children, and religion. MANOVA will be used to assess pre/post-test differences across variables.

02

Conditions studied

  • Social Stigma

Browse trials for

Keywords

  • Stigma
  • lesbian
  • gay
  • bisexual
  • transgender
03

In context

Social Stigma

266 studies on the registry are indexed under Social Stigma; 66 are open to participants now.

This study's enrollment of 106 is below the median of 139 across 217 interventional studies indexed under Social Stigma.

Browse Social Stigma studies →

Lead sponsor

University of Toronto is the lead sponsor of 403 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must be 18 years of age or older for being able to give and be willing to complete a follow up survey.

Exclusion criteria

Exclusion Criteria:

  • Participants who are 17 years of age or younger were exuded for not being able to give .
  • Participants who were unwilling to complete a follow up survey were also excluded.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    LGBT Stigma Reduction Intervention

    Participants will complete a pre-test, followed by a performance ethnography where they will watch theatre performances that illustrate stigma experienced by LGBT persons in Swaziland and Lesotho. They will have the opportunity to participate in these theatre performances to demonstrate reduced stigma and increased acceptance of LGBT persons. They will then complete a post-test, followed by a 6 week follow up survey.

    Other: LGBT Stigma Reduction Intervention

Interventions

  • OtherLGBT Stigma Reduction Intervention

    Participants will complete a pre-test, followed by a performance ethnography where they will watch theatre performances that illustrate stigma experienced by LGBT persons in Swaziland and Lesotho. They will have the opportunity to participate in these theatre performances to demonstrate reduced stigma and increased acceptance of LGBT persons. They will then complete a post-test, followed by a 6 week follow up survey.

06

What researchers measure

Primary outcomes

  1. Attitudes towards lesbian and gay men scale

    assesses attitudes and stereotypes regarding LGBT persons

    Time frame: 3 months

Secondary outcomes

  1. HIV-related stigma

    attitudes towards people living with HIV

    Time frame: 3 months

  2. Civic participation

    Time frame: 3 months

07

Study locations

2 sites
  • Maluti School of Nursing
    Maseru, Lesotho
  • Southern Africa Nazarene University
    Manzini, M200, Swaziland
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2015, a primary completion of Jun 2015 and a completion of Jun 2015. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2015
First posted
Apr 7, 2015
Start
Feb 2015
Primary completionActual
Jun 2015
CompletionActual
Jun 2015
Last update
Apr 13, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02410434
Responsible party
Carmen Logie, MSW, PhD (Assistant Professor, University of Toronto) — Principal investigator
First posted
Apr 7, 2015
Start date
Feb 2015
Primary completion
Jun 2015
Completion
Jun 2015
Last update
Apr 13, 2016

Study contacts

Carmen Logie, PhD
principal investigator · University of Toronto, Factor-Inwentash Faculty of Social Work

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion